Categories
Cardiovascular
Diagnostics
Endocrinology
Health Insurance
Medical Devices
Mental Health
Nutrition
Oncology
Public Health
Sexual Health
Popular Articles

HIV Transmission In Europe Occurs Primarily In Vacation Destinations, Study Finds
HIV in Europe is transmitted primarily in vacation destinations, according to a study published recently in the journal Retrovirology, the PA/Google.com reports. For the study, researchers led by Dimitrios Paraskevis of the University of Athens analyzed samples of HIV-1 subtype B virus, the most prevalent form of HIV in Europe, from 16 European countries and Israel (PA/Google.com, 5/20). The researchers created a family tree of the virus and examined its genetic characteristics to determine how it has evolved.The study found that tourists are more likely to contract HIV in Greece, Portugal, Serbia and Spain, which are popular vacation destinations. Meanwhile, HIV-positive people in Austria, Belgium, Denmark and Luxembourg are more likely to have contracted the virus outside of these countries. The study also found that HIV-positive people in Israel, Norway, the Netherlands, Sweden, Switzerland and the United Kingdom contract the virus both within these countries and in other countries. In addition, the study found that in Poland the virus spread mainly among residents through injection drug use. "Viruses move around with travelers -- thus health programs within countries should not only target the national populations, prevention efforts must also be aimed at migrants, travelers and tourists -- who are both major s and targets of HIV," Paraskevis said (BBC News, 5/20). Lisa Power, head of policy at the Terrence Higgins Trust, said that the findings are not a "surprise," adding, "We"ve known for some time with high levels of mobility in the world these days that it"s very easy for viruses to move around. What it tells us is that you can"t limit HIV prevention and support just to permanent residents" (PA/Google.com, 5/20).
generic viagra online
Eiger BioPharmaceuticals Acquires Exclusive License To Novel Hepatitis C Virus (HCV) Technology From Stanford University
Eiger BioPharmaceuticals, Inc., a biotechnology company developing antiviral therapies, announced today that it has licensed the exclusive worldwide rights to novel Hepatitis C Virus (HCV) technology from Stanford University. This technology, discovered in the lab of Stanford scientist and Eiger founder Dr. Jeffrey Glenn, M.D., Ph.D., is focused on a variety of novel targets, including key features of NS4B, a non-structural protein in the HCV genome, which binds to HCV-RNA and is required for viral replication.
News of the day
Lower College GPA And Evening Chronotype In High School Students Linked
According to a research abstract at SLEEP 2009, the 23rd Annual Meeting of the Associated Professional Sleep Societies, students who consider themselves to be evening types (that is someone who feels more alert and does their best work later in the day) have poorer sleep hygiene scores than morning and intermediate types. Sleep hygiene is the group of behaviors linked to good sleep and alertness. Examples include having a regular bedtime routine, a regular wake time, a regular bed time, and sleeping in a comfortable bed. The researchers found that this poor sleep hygiene was related to poorer academic performance and a decline in grade point average (GPA) during the transition from high school to college.
Medical Devices

UK Dementia Research Funding Must Triple, Say Experts

The UK"s leading dementia charities united with eminent scientists to urge the government to commit to a national dementia research strategy and triple annual investment to ÷£96 million in five years. The Alzheimer"s Research Trust and Alzheimer"s Society revealed that the UK government lags behind France, Germany and the US in dementia research funding and has no plans for the future. They called on the government to exploit the UK"s huge scientific talent and lead the world in the race for a cure. In a joint statement launched ahead of the government"s forthcoming Dementia Research Summit due to take place this summer, the charities set out priorities and opportunities for dementia research. Significant opportunities in dementia research include improving diagnosis, genetic research, improving care, and utilising the NHS in clinical trials. Neil Hunt, Chief Executive of Alzheimer"s Society, says, "Dementia is the health challenge of our generation, it is absolutely vital that dementia research funding is tripled. One million people will develop dementia in the next ten years, yet the government invests just 2% of its medical research budget on dementia. The Dementia Research Summit must be more than just a talking shop. It is a crucial opportunity for the government, charities and stakeholders to commit to a shared vision for dementia research. We need an ambitious plan that drives change and defeats this devastating condition." Rebecca Wood, Chief Executive of the Alzheimer"s Research Trust, says, "700,000 people in the UK live with dementia, costing our economy ÷£17 billion annually. Given the stakes, the government cannot afford to get its dementia research policy wrong. "Spending ÷£96 million per year would put the UK proportionately on a par with other world-leaders like the United States, and bring funding per person with dementia up to a similar level to government investment in cancer research." Notes The Alzheimer"s Research Trust and Alzheimer"s Society"s joint statement calls for - A comprehensive plan that addresses cause, cure, care and public health research. - Joint engagement by the government, the research community, charities, people with dementia, carers and pharmaceutical companies to make this happen. - Actions to make NHS patients routinely aware that they may participate in research studies. - Steps to support and grow the dementia research community to meet the growing research demands over the next five years. About the Alzheimer"s Research Trust The Alzheimer"s Research Trust is the UK"s leading dementia research charity and provides free information on Alzheimer"s disease and related dementias: phone 01223 843899 or visit http://www.alzheimers-research.org.uk. The charity relies solely on public donations to fund its research. Alzheimer"s Society


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):

© Copyright 2009